AB
SLDB icon

Amalgamated Bank’s Solid Biosciences SLDB Stock Holding History

Amalgamated Bank’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,852
Closed -$10K – 2632
2025
Q4 		$10K Buy
1,852
+1,073
+138% +$5.82K ﹤0.01% 2434
2025
Q3 		$5K Hold
779
– – ﹤0.01% 2793
2025
Q2 		$4K Hold
779
– – ﹤0.01% 2874
2025
Q1 		$3K Hold
779
– – ﹤0.01% 2805
2024
Q4 		$3K Hold
779
– – ﹤0.01% 2873
2024
Q3 		$5K Hold
779
– – ﹤0.01% 2779
2024
Q2 		$4K Buy
+779
New +$6.98K ﹤0.01% 2882
2022
Q2 		– Sell
-479
Closed -$9K – 3181
2022
Q1 		$9K Buy
+479
New +$8.45K ﹤0.01% 2978

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Amalgamated Bank's SLDB Position: Q1 2026 in Review

Amalgamated Bank sold out of Solid Biosciences (SLDB) in Q1 2026, closing a stake of 1,852 shares — an estimated $10K sold.

Amalgamated Bank first reported a position in SLDB in Q1 2022 and held it in 8 quarters. The position peaked at $10K in Q4 2025. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Amalgamated Bank reported no remaining Solid Biosciences position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,852 Solid Biosciences shares in Q1 2026, an estimated $10K.
  • Amalgamated Bank first reported a position in Solid Biosciences in Q1 2022 and held it in 8 quarters.
  • Amalgamated Bank's Solid Biosciences position peaked at $10K in Q4 2025.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.